Status:
UNKNOWN
Saliva Insulin Responses to a Standardized Meal Tolerance Test in Humans
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Mitacs
Core-Health Technologies Inc.
Conditions:
Diet Modification
Insulin Resistance
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
Recent evidence suggests that hyperinsulinemia (i.e., elevated insulin levels) is the primary causative factor in obesity. Insulin promotes fat storage and prevents fat breakdown, suggesting that weig...
Eligibility Criteria
Inclusion
- non-smoker
- have a body mass index greater than 18.5 kg/m2
- have not been diagnosed with type 2 diabetes or other medical conditions affecting glucose or insulin levels
Exclusion
- You have been. diagnosed with diabetes (fasting blood sugar more than 7.0 mmol/l) or any other diagnosed chronic condition that may impact your glucose or insulin levels or the outcomes of this study.
- You take any medication which may affect your glucose and insulin level
- Unable to travel to make your testing appointments.
- Unable to consume the meal tolerance test drink/shake and/or provide finger stick glucose or saliva samples for the study.
Key Trial Info
Start Date :
January 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04309071
Start Date
January 4 2019
End Date
September 1 2022
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan
Kelowna, British Columbia, Canada, V1V 3G1